Gender- and Age-Related Prescription Drug Use Patterns

OBJECTIVE: To report the top 15 prescription drug categories used by males and females of all ages and to compare this information with national prevalence data. METHODS: Data used were pharmacy claim and eligibility information over the period January 1, 1999, through December 31, 1999, for 1 294 295 members of a large pharmacy benefit manager. Participant ages ranged from 1 to more than 100 years. Each participant was assigned to 1 of 9 age categories. Use of a drug category was defined as filling at least 1 prescription for a medication in that category during the study year. The percentage of males and females that used each drug group was established, and the 15 drug groups used most frequently were reported for each age category. RESULTS: Most gender differences in medication use appear after or around the puberty years. Women are more likely to use several classes of medications, including antidepressants and antianxiety and pain medications. Except for diuretics, men use cardiovascular medications at an earlier age than do women. The use of medications for chronic conditions increases with older age categories for both genders. The use of female hormones represents only a small proportion of the difference in medication use between genders. CONCLUSIONS: Analysis of data from the epidemiologic literature suggests that the gender differences in medication use shown in this study generally are to be expected.

[1]  M. Rutter,et al.  Effects of age and pubertal status on depression in a large clinical sample , 1992, Development and Psychopathology.

[2]  J. Cauley,et al.  Prevalence and determinants of estrogen replacement therapy in elderly women , 1990, American journal of obstetrics and gynecology.

[3]  P. Burney,et al.  Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. , 2000, American journal of respiratory and critical care medicine.

[4]  C. Furberg,et al.  Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. , 2000, Archives of internal medicine.

[5]  J. Manson,et al.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[6]  C. Schoenborn,et al.  Current estimates from the National Health Interview Survey. , 1988, Vital and health statistics. Series 10, Data from the National Health Survey.

[7]  P W Wilson,et al.  Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. , 1985, The New England journal of medicine.

[8]  Myron Genel,et al.  Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 1998 .

[9]  A. Timmis,et al.  Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. , 2000, American heart journal.

[10]  D. Rubinow,et al.  The Perimenopause and Affective Disorders , 1997, Seminars in reproductive endocrinology.

[11]  A. Chandra,et al.  Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. , 1997, Vital and health statistics. Series 23, Data from the National Survey of Family Growth.

[12]  M. Ganguli,et al.  Use of Prescription Medications in an Elderly Rural Population: The Movies Project , 1996, The Annals of pharmacotherapy.

[13]  P. F. Adams,et al.  Current estimates from the National Health Interview Survey, 1991. , 1992, Vital and health statistics. Series 10, Data from the National Health Survey.

[14]  E. Frank,et al.  Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. , 2000, Archives of general psychiatry.

[15]  J. Madans,et al.  Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. , 1997, American journal of epidemiology.

[16]  A. King,et al.  Are women using postmenopausal estrogens? A community survey. , 1990, American journal of public health.

[17]  E. Skobeloff,et al.  The influence of age and sex on asthma admissions. , 1992, JAMA.

[18]  Phil A. Silva,et al.  DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. , 1987, Archives of general psychiatry.

[19]  J. Brook,et al.  Family factors related to the persistence of psychopathology in childhood and adolescence. , 1987, Psychiatry.

[20]  D. Safer,et al.  Increased methylphenidate usage for attention deficit disorder in the 1990s. , 1996, Pediatrics.

[21]  S. Kornstein Gender differences in depression: implications for treatment. , 1997, The Journal of clinical psychiatry.

[22]  F. Whittington,et al.  Sex differences in prescription drug use of older adults. , 1981, Journal of psychoactive drugs.

[23]  J. McPhillips,et al.  Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. , 1993, American journal of epidemiology.

[24]  P. Slanetz,et al.  Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. , 1998, JAMA.

[25]  J. Hanlon,et al.  Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. , 1992, Journal of gerontology.

[26]  C. Infante-Rivard,et al.  Otitis media in children: frequency, risk factors, and research avenues. , 1993, Epidemiologic reviews.

[27]  H. Lawson,et al.  Treatment of acute myocardial infarction and 30-day mortality among women and men. , 2000, The New England journal of medicine.

[28]  E. Barrett-Connor,et al.  Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. , 1988, American journal of epidemiology.

[29]  R. Rooks,et al.  Ambulatory health care visits by children: principal diagnosis and place of visit. , 1998, Vital and health statistics. Series 13, Data from the National Health Survey.

[30]  J. Hibbard,et al.  Another look at sex differences in the use of medical care: illness orientation and the types of morbidities for which services are used. , 1986, Women & health.

[31]  B. Birmaher,et al.  Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[32]  C. Metge,et al.  The population's use of pharmaceuticals. , 1999, Medical care.

[33]  T. Pigott,et al.  A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. , 1999, The Journal of clinical psychiatry.

[34]  S. Oliveria,et al.  Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. , 1999, Archives of internal medicine.

[35]  M. Wolraich,et al.  Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991 .

[37]  R. Muñoz Anxiety disorders. , 1986, New directions for mental health services.

[38]  D. Sclar,et al.  Anxiety Disorders in the USA, 1990 to 1997 , 2000 .

[39]  S. Shapiro Postmenopausal estrogen use and heart disease. , 1987, The New England journal of medicine.

[40]  J. Gore,et al.  Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. , 1998, Archives of internal medicine.

[41]  S. Schappert National Ambulatory Medical Care Survey: 1991 summary. , 1993, Advance data.

[42]  R. Rosenfeld An evidence-based approach to treating otitis media. , 1996, Pediatric clinics of North America.

[43]  A. J. Robins,et al.  Depression in a sample of 9-year-old children, Prevalence and associated characteristics. , 1983, Archives of general psychiatry.

[44]  D. Goldenberg Fibromyalgia, chronic fatigue syndrome, and myofascial pain. , 1996, Current opinion in rheumatology.

[45]  R. Lipton,et al.  Migraine in the United States: A review of epidemiology and health care use , 1993, Neurology.

[46]  L H Kuller,et al.  Characteristics of noncontraceptive hormone users. , 1988, Preventive medicine.

[47]  H. Britt,et al.  Sex differences in prescribed medications: another case of discrimination in general practice. , 1997, Social science & medicine.

[48]  T. Pigott,et al.  Gender differences in the epidemiology and treatment of anxiety disorders. , 1999, The Journal of clinical psychiatry.

[49]  M. Criqui,et al.  Postmenopausal estrogen use and heart disease risk factors in the 1980's. Rancho Bernardo, Calif, Revisted , 1989 .

[50]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[51]  E. Susser,et al.  Divalproex treatment of disruptive adolescents: a report of 10 cases. , 1997, The Journal of clinical psychiatry.

[52]  D. Sclar,et al.  National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995 , 1999, Clinical pediatrics.

[53]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[54]  L. Scahill,et al.  Epidemiology of ADHD in school-age children. , 2000, Child and adolescent psychiatric clinics of North America.

[55]  J. Seidell,et al.  Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension , 1998, Journal of hypertension.

[56]  E. Barrett-Connor,et al.  Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited. , 1989, JAMA.

[57]  N. Breslau,et al.  Traumatic events and posttraumatic stress disorder in an urban population of young adults. , 1991, Archives of general psychiatry.

[58]  M M Weissman,et al.  Lifetime prevalence of specific psychiatric disorders in three sites. , 1984, Archives of general psychiatry.

[59]  D. Castell,et al.  Symptomatic gastroesophageal reflux: Incidence and precipitating factors , 1976, The American Journal of Digestive Diseases.

[60]  D. Mechanic,et al.  Gender Differences in the Acquisition of Prescribed Drugs: An Epidemiological Study , 1987, Medical care.

[61]  D. Safer,et al.  A survey of medication treatment for hyperactive/inattentive students. , 1988, JAMA.

[62]  D. Cherry,et al.  National Ambulatory Medical Care Survey: 1999 Summary , 2001 .